Editorial: Confronting the professional liability crisis (Part 2)

"The FDA did not raise any concern regarding the general approvability of elinzanetant in its correspondence," according to an anouncement from Bayer.

In this episode of Pap Talk, Jean Dubuisson, MD, PhD, discusses the first successful hysterectomy performed using the MIRA surgical system.

A new study finds that intrahepatic cholestasis of pregnancy diagnosis before 32-weeks’ gestation increases the risk of adverse outcomes.

A study finds that a uniform labor induction protocol did not reduce racial disparities in cesarean deliveries or maternal health outcomes.

The FDA has granted Priority Review to expand flibanserin (Addyi; Sprout Pharmaceuticals) use to postmenopausal women, potentially broadening access to treatment for hypoactive sexual desire disorder.